A033270 Stock Overview
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
Korea United Pharm Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩22,800.00 |
| 52 Week High | ₩30,600.00 |
| 52 Week Low | ₩20,900.00 |
| Beta | 0 |
| 1 Month Change | -3.39% |
| 3 Month Change | -11.63% |
| 1 Year Change | 6.29% |
| 3 Year Change | -57.30% |
| 5 Year Change | -12.48% |
| Change since IPO | 696.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| A033270 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 2.5% | -3.8% | -3.3% |
| 1Y | 6.3% | 3.6% | 1.2% |
Return vs Industry: A033270 exceeded the KR Pharmaceuticals industry which returned 3.6% over the past year.
Return vs Market: A033270 exceeded the KR Market which returned 1.2% over the past year.
Price Volatility
| A033270 volatility | |
|---|---|
| A033270 Average Weekly Movement | 3.1% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A033270 has not had significant price volatility in the past 3 months.
Volatility Over Time: A033270's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Duk-Young Kang | www.kup.co.kr |
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries.
Korea United Pharm Inc. Fundamentals Summary
| A033270 fundamental statistics | |
|---|---|
| Market cap | ₩335.42b |
| Earnings (TTM) | ₩20.02b |
| Revenue (TTM) | ₩161.44b |
0.0x
P/E Ratio0.0x
P/S RatioIs A033270 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A033270 income statement (TTM) | |
|---|---|
| Revenue | ₩161.44b |
| Cost of Revenue | ₩76.64b |
| Gross Profit | ₩84.80b |
| Other Expenses | ₩64.78b |
| Earnings | ₩20.02b |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A033270 perform over the long term?
See historical performance and comparison